Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome
Status:
Recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
sICASBLM is a prospective controlled trial, to asses the impact of improving blood lipid
management on clinical outcome of moderate to severe symptomatic intracranial atherosclerotic
stenosis patients (LDL-C>1.8mmol/L) without endovascular therapy.
Phase:
N/A
Details
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University